Loading people...
Naimish Patel is a Venture Partner at Hyperplane Venture Capital based in Boston, Massachusetts. In this role since 2019, he focuses on seed and Series B investments across data services, biotechnology, and artificial intelligence, deploying capital ranging from $250,000 to $3 million per transaction. Prior to joining the venture capital sector, Patel served as the Founder and Chief Executive Officer of Gridco Systems from 2010 until its acquisition in 2017, and previously held the position of Chief Technology Officer at Sycamore Networks. His earlier career includes serving as an Executive in Residence at General Catalyst and earning bachelor's and master's degrees in electrical engineering and physics from the Massachusetts Institute of Technology. Patel leverages his extensive operational leadership and technical engineering background to advise and invest in early-stage emerging technology enterprises across multiple sectors.
Naimish Patel is Chief Medical Officer at CRISPR Therapeutics, based in Boston, MA, USA.